Brainstorm Cell Therapeut... (BCLI)
NASDAQ: BCLI
· Real-Time Price · USD
0.60
0.00 (0.00%)
At close: Aug 15, 2025, 12:41 PM
13F Institute Ownership
Total Institutes of 31 in Brainstorm Cell Therapeutics reduced their positions with a decrease of 1 investors compared to the previous quarter. An additional 610.4K shares, as total invested capital grew by $532.79K with ownership percentage increasing from 4.81% to 16.31%.
Top Shareholders
| Institute | Ownership | Shares | Shares % Change | Market Value | Portfolio | Filing Date |
|---|---|---|---|---|---|---|
| Armistice Capital, LLC | 13.01% | 690.67K | +100.00% | 870.24K | 0.01% | May 15, 2025 |
| Geode Capital Management, LLC | 1.10% | 58.16K | +10.79% | 73.3K | < 0.01% | May 13, 2025 |
| Vanguard Group Inc | 0.52% | 27.72K | -64.66% | 34.93K | < 0.01% | May 09, 2025 |
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.